ArticleScientific reports2025

Alvespimycin is identified as a novel therapeutic agent for diabetic kidney disease by chemical screening targeting extracellular vesicles.

Daisuke Fujimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.